Hemgenix now approved, Paul Perreault plans his exit from CSL; LianBio president hands in resignation

Paul Perreault

→ As CSL trends upward, Paul Perreault will soon step down, putting one of his lieutenants in the top spot.

Paul McKenzie, the COO at the Australian pharma since 2019, will become CSL’s chief executive on March 6, while Perreault lends a...

Click to view original post